Evras SA
The score of Evras shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -51 % Total assets -66 %
Accounts of the company itself (not consolidated).
The full file covers 12 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Evras's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 14 Jul 2025
- Year ended 31 Dec 2023filed on 06 Aug 2024
- Year ended 31 Dec 2022filed on 23 Aug 2023
- Year ended 30 Sep 2021filed on 22 Mar 2022
Evras's financial analysis
- Solvency43.1%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Evras
Evras's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0417.723.174
- VAT number
- BE0417723174
- Peppol
- Registered · 0208:0417723174 · as of 09 Nov 2026
- Legal form
- SA
- Incorporated
- 25 Nov 1977
- Registered office
- 7080 Frameries
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Evras (SA) has been based in Frameries since 1977, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 1,560 € and equity of 57,345 €; its revenue is not published. Its solvency stands at 43.1%, above the median of its sector (41.5%).
Companies similar to Evras
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Delaunoy Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 522,244 €
- Apotheek De Vijzel Retail sale of pharmaceutical products Zoersel · balance sheet 509,493 €
- Marc Thoné Retail sale of pharmaceutical products Antwerp · balance sheet 93,815 €
- F-88 Retail sale of pharmaceutical products Bree · balance sheet 170,105 €
- Lynapharma Retail sale of pharmaceutical products Saint-Gilles · balance sheet 177,178 €
- De Hermitage Retail sale of pharmaceutical products Bruges · balance sheet 202,742 €
- I & CM Patriotes Retail sale of pharmaceutical products Brussels · balance sheet 322,247 €
- Temmerman Retail sale of pharmaceutical products Ghent · balance sheet 349,257 €
Frequently asked questions about Evras
What is the revenue of Evras?
Evras files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Evras?
In Belgium, the VAT number is the company number prefixed with BE: BE0417723174 for Evras, if the company is VAT-registered. Its company number (CBE) is 0417.723.174.
Where is the registered office of Evras?
According to the CBE register, the registered office of Evras is in 7080 Frameries.
What is the equity of Evras?
At the close of the 2025 financial year, the equity of Evras amounts to 57,345 €, a solvency of 43.1% of total assets.
Who manages Evras?
The register lists 5 active mandates at Evras. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Evras
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →